🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human Epidermal Growth Factor Receptor 3 (HER3) expression is seen across a...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-26
Trial ID
NCT01966445
Treatments Being Tested
This is a multi-center , open-label, phase 1/2 study to evaluate the safety...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-27
Trial ID
NCT06712680
Treatments Being Tested
Glioblastoma (GBM) comprises about 16% of all malignancies of the nervous s...
Status
Withdrawn
Location
John Wayne Cancer Institute
Start Date
2016-09
Trial ID
NCT02876003
Treatments Being Tested
The purpose of the protocol is to determine the effect of BN83495 on the pr...
Status
Terminated
Location
Dept of Obstetrics and Gynecology, Medical College of Georgia
Start Date
2010-11
Trial ID
NCT01251354
Treatments Being Tested
In this single arm, open label, phase 2 trial, operable patients with stage...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2022-08-04
Trial ID
NCT05800756
Treatments Being Tested
This is an Open-label, Single Arm study to observe the safety and tolerabil...
Status
Unknown
Location
Shanghai Tenth People's Hospital
Start Date
2021-10-29
Trial ID
NCT05070156
Multicenter, open label, three-arm randomized trial to assess the effect of...
Status
Recruiting
Location
Gemelli
Start Date
2022-03-01
Trial ID
NCT05089695
Treatments Being Tested
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
This phase I, first-in-human dose-escalation study was conducted to determi...
Status
Completed
Location
Guangdong General Hospital
Start Date
2016-04
Trial ID
NCT02896231
Treatments Being Tested
This study is a multi-center, open-label, dose-esclation I/Ib clinical stud...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2017-09-06
Trial ID
NCT04103853
Treatments Being Tested